Category: Oncology/Hematology
Global Oncology/Hematology
-
Global Castrate Resistant Prostate Cancer Therapeutics Market - 2022-2029
... growing at a CAGR of 8.4% during the forecast period (2022-2029). Castration-resistant prostate cancer is stated as prostate cancer that is scattered to other parts of the body. Several risk factors for castration-resistant prostate cancer ... Read More
-
Global Cancer Molecular Diagnostics Market - 2022-2029
... CAGR of 6.30% during the forecast period (2022-2029). Cancer molecular diagnostics include the detection, diagnosis, sub-classification, prognosis, and monitoring response to therapy. These techniques identify the alterations in DNA or RNA sequences, associated with cancer. ... Read More
-
Global Oncology Therapy Market - 2022-2029
... during the forecast period (2022-2029). Cancer therapies are medications designed to limit cancer growth and proliferation by interfering with specific molecules involved in the growth and expansion of malignant cells, such as proteins or DNA. ... Read More
-
Companion Diagnostics for Oncology Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Companion Diagnostics for Oncology market size is growing at a ... Read More
-
Global Hematology Market - 2022-2029
... % during the forecast period (2022-2029). Hematology is a branch of medicine that deals with diagnosing, treating, and preventing blood, blood-forming organs, and blood diseases such as blood cancer, anemia, hemophilia, and blood clots. Hematological ... Read More
-
Global Cervical Cancer Treatment Market - 2022-2029
... cervix is the lower part of the uterus that connects to the vagina. Cervical cancer begins in the cells of the cervix. Most cervical malignancies are caused by strains of the sexually transmitted pathogen, Human ... Read More
-
Global Cancer Vaccines Market - 2022-2029
... forecast period (2022-2029). Cancer is a malignant tumor caused by uncontrollable cell development in the body. It can be treated with a variety of drugs and vaccinations. Vaccines are widely classified as either preventative or ... Read More
-
Global Cancer Treatment Drugs Market - 2022-2029
... of 10.6% during the forecast period (2022-2029). The widespread prevalence of cancer leads to the rapid development of cancer treatment drugs. Various drugs have received regulatory approval from the USFDA (Food and Drug Administration) the ... Read More
-
Global Skin Cancer Market - 2022-2029
... to abnormal growth of skin cells. It is estimated that 90% of skin cancer is caused majorly due to solar and artificial ultraviolet radiation (UV). Ultraviolet radiation is a primary carcinogen that results in UV-induced ... Read More
-
Global Neuroendocrine Cancer Market - 2022-2029
... during the forecast period (2022-2029). Neuroendocrine tumors are tumors that start in specialized neuroendocrine cells. Nerve cells and hormone-producing cells share characteristics with neuroendocrine cells. Market Dynamics The increasing research and development and the growing ... Read More
-
Global Cancer Stem Cells Market - 2022-2029
... stem cells are uncommon immortal cells seen in tumors that give rise to a diverse range of cell types that make up the tumor. These cells have been found in a number of human malignancies ... Read More
-
Global Urinary Tract Cancer Market Size study & Forecast, by Cancer Type (Bladder Cancer, Urethral cancer and Ureteric and Renal Pelvic Cancer), Treatment Type (Chemotherapy, and Immunotherapy), and Distribution Channel (Retail Pharmacy, and Online Pharmacy) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Urinary Tract Cancer Market is valued approximately USD 2.02 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.6% over the forecast period ... Read More
-
Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022-2027
... in oncology market size was valued at US$2045 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 23.7% during 2022-2027. The gene therapy in oncology market report provides ... Read More
-
Global Stomach Cancer Treatment Market Size study & Forecast, by Type (Chemotherapy, Radiotherapy, Immunotherapy, Targeted Drug Therapy, Surgery), by End-users (Hospital Pharmacies, Specialty & Retail Pharmacies, Others) and Regional Analysis, 2022-2029
... Market is valued at approximately USD 3.83 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2022-2029. Stomach cancer also commonly known as ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029
... Component [Datasets (Clinical, Claims, Pharmacy), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029 The U.S. RWE solutions market is expected to grow at a CAGR of ... Read More
-
Global Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation Global Lung Cancer Surgery Market, By Product ... Read More
-
Liver Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Cholangio Carcinoma, Hepatocellular Carcinoma, Hepatoblastoma, Others); By Treatment Type; By Region; Segment Forecast, 2022 - 2030
... to reach USD 10.48 billion by 2030, according to a new study by Polaris Market Research. The report “Liver Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Cholangio Carcinoma, Hepatocellular Carcinoma, Hepatoblastoma, Others); ... Read More
-
Nephrology and Urology Devices Market Share, Size, Trends, Industry Analysis Report, By Application (Urolithiasis, Urological Cancer & BPH, Bladder Disorders, Kidney Diseases, Others); By Product; By End-Use; By Region; Segment Forecast, 2022 - 2030
... global nephrology and urology devices market size is expected to reach USD 9.33 billion by 2030, according to a new study by Polaris Market Research. The report “Nephrology and Urology Devices Market Share, Size, Trends, ... Read More
-
Lung Cancer Screening Market By Type (Low-dose computed tomography (LDCT), X-ray), By Age group (50 and older, Below 50), By End User (Hospitals, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... lung cancer screening market was valued at $879.59 million in 2021, and is projected to reach $1,853.04 million by 2031, registering a CAGR of 7.7% from 2022 to 2031. Lung cancer screening refers to methods ... Read More
-
Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Epithelial Tumors, Germ Cell Tumors, Stromal Tumors, and Primary Peritoneal Cancer); By Diagnosis; By Therapeutic Treatment; By End-User; By Region; Segment Forecast, 2022 - 203
... 2030 The global ovarian cancer market is expected to reach USD 9.67 billion by 2030, according to a new study by Polaris Market Research. The report “Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Others); By Diagnosis; By Cancer Type, By End-Users; By Region; Segment Forecast, 2022 - 2030
... global pancreatic cancer market size is expected to reach USD 7.04 million by 2030, according to a new study by Polaris Market Research. The report “Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
Global Multi Cancer Early Detection Market Size study, By Type (Liquid Biopsy, Gene Panel, LDT, & Others), By End-User (Hospitals, Diagnostic Laboratories, Others), and Regional Forecasts 2022-2028
... at approximately USD 791.58 million in 2021 and is anticipated to grow with a healthy growth rate of more than 15.0% over the forecast period 2022-2028. Multi-cancer detection (MCD) measure biological signals that may be ... Read More
-
Global Undifferentiated Pleomorphic Sarcoma Therapeutics Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). Soft tissue cancers include malignant fibrous histiocytoma, often undifferentiated pleomorphic sarcoma. It's rare cancer that frequently metastasizes to other body regions and returns after ... Read More
-
Global Cutaneous Squamous Cell Carcinoma Market - 2022-2029
... a CAGR of 7.2 % during the forecast period (2022-2029). Cancer starts in the cells that make up the epidermis (the outer layer of the skin). It commonly develops in parts of the skin that ... Read More
-
Global Wearable Injectors Market Size study, By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Other), By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Other), By End User (Hospital, Clinic, Home Care, Other), and Regional Forecasts 2022-2028
... Care, Other), and Regional Forecasts 2022-2028 Global Wearable Injectors Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
Research Assistance
